India to United States: Metformin Export Trade Route
India has recorded 3,889 verified shipments of Metformin exported to United States, representing a combined trade value of $180.6M USD. This corridor is served by 38 active Indian exporters, with an average shipment value of $46.4K USD. The leading Indian exporter is GRANULES INDIA LIMITED, which accounts for 60% of total export value with 2,114 shipments worth $107.8M USD. On the buying side, GRANULES PHARMACEUTICALS INC is the largest importer in United States with $36.6M USD in purchases. The top 3 suppliers — GRANULES INDIA LIMITED, INVENTIA HEALTHCARE LIMITED, ZYDUS LIFESCIENCES LIMITED — together control 81% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Metformin corridor is one of India's established pharmaceutical export routes, with 3,889 shipments documented worth a combined $180.6M USD. The route is dominated by GRANULES INDIA LIMITED, which alone accounts for roughly 60% of all export value, reflecting the consolidated nature of India's metformin manufacturing sector.
Across 38 active suppliers, the average shipment value stands at $46.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with metformin's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 12.0%, placing it at rank #6 among India's top metformin export destinations globally.
On the import side, key buyers of Indian metformin in United States include GRANULES PHARMACEUTICALS INC, GRANULES PHARMACEUTICALS, INC, ASCEND LABORATORIES LLC and 94 others. GRANULES PHARMACEUTICALS INC is the single largest importer with 625 shipments valued at $36.6M USD.
Route Characteristics
- Average transit18 days
- Peak seasonQ1
- Primary modeSea freight
- Top portHYDERABAD ICD
Market Position
- Global rank#6
- Annual growth+12.0%
- Demand growth+10.7%
- Regulatory ease78/100
Top 10 Indian Metformin Exporters to United States
Showing top 10 of 38 Indian suppliers exporting Metformin to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GRANULES INDIA LIMITED Avg $51.0K per shipment | 2,114 | $107.8M | 59.7% |
| 2 | INVENTIA HEALTHCARE LIMITED Avg $75.9K per shipment | 341 | $25.9M | 14.3% |
| 3 | ZYDUS LIFESCIENCES LIMITED Avg $33.6K per shipment | 353 | $11.9M | 6.6% |
| 4 | ALKEM LABORATORIES LIMITED Avg $44.1K per shipment | 165 | $7.3M | 4.0% |
| 5 | MYLAN LABORATORIES LIMITED Avg $41.4K per shipment | 151 | $6.2M | 3.5% |
| 6 | MARKSANS PHARMA LIMITED Avg $43.2K per shipment | 124 | $5.4M | 3.0% |
| 7 | HARMAN FINOCHEM LIMITED Avg $25.1K per shipment | 143 | $3.6M | 2.0% |
| 8 | CADILA HEALTHCARE LIMITED Avg $52.8K per shipment | 40 | $2.1M | 1.2% |
| 9 | AUROBINDO PHARMA LIMITED Avg $53.5K per shipment | 38 | $2.0M | 1.1% |
| 10 | LUPIN LIMITED Avg $36.3K per shipment | 39 | $1.4M | 0.8% |
This table shows the top 10 of 38 Indian companies exporting metformin to United States, ranked by total trade value. The listed exporters are: GRANULES INDIA LIMITED, INVENTIA HEALTHCARE LIMITED, ZYDUS LIFESCIENCES LIMITED, ALKEM LABORATORIES LIMITED, MYLAN LABORATORIES LIMITED, MARKSANS PHARMA LIMITED, HARMAN FINOCHEM LIMITED, CADILA HEALTHCARE LIMITED, AUROBINDO PHARMA LIMITED, LUPIN LIMITED. GRANULES INDIA LIMITED is the dominant supplier with 2,114 shipments worth $107.8M USD, giving it a 60% market share. The top 3 suppliers together account for 81% of the total trade value on this route.
Showing top 10 of 38 total Indian exporters on the India to United States Metformin export route.
Top 10 Metformin Importers in United States
Showing top 10 of 97 known buyers in United States receiving Metformin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian metformin in United States include GRANULES PHARMACEUTICALS INC, GRANULES PHARMACEUTICALS, INC, ASCEND LABORATORIES LLC, GRANULES PHARMACEUTICALS, INC., EVERSANA LIFE SCIENCE SERVICES, among 97 total buyers. The largest importer is GRANULES PHARMACEUTICALS INC, accounting for $36.6M USD across 625 shipments — representing 20% of all metformin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GRANULES PHARMACEUTICALS INC | 625 | $36.6M | 20.3% |
| 2 | GRANULES PHARMACEUTICALS, INC | 679 | $26.1M | 14.5% |
| 3 | ASCEND LABORATORIES LLC | 338 | $25.4M | 14.1% |
| 4 | GRANULES PHARMACEUTICALS, INC. | 571 | $25.2M | 14.0% |
| 5 | EVERSANA LIFE SCIENCE SERVICES | 400 | $14.5M | 8.0% |
| 6 | MYLAN PHARMACEUTICALS INC | 155 | $8.7M | 4.8% |
| 7 | ASCEND LABORATORIES,LLC | 154 | $8.5M | 4.7% |
| 8 | PRIORITY HEALTHCARE DISTRIBUTION | 50 | $4.4M | 2.4% |
| 9 | ASCEND LABORATORIES LLC, | 52 | $3.8M | 2.1% |
| 10 | TIME-CAP LABS, | 67 | $2.9M | 1.6% |
Showing top 10 of 97 Metformin importers in United States on this route.
Top 10 Metformin Formulations Imported by United States
Showing top 10 of 2,121 product formulations shipped on the India to United States Metformin route, ranked by trade value
United States imports a wide range of metformin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — METFORMIN HYDROCHLORIDE TABLETS USP 1000 — accounts for $3.6M USD across 58 shipments. There are 2,121 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | METFORMIN HYDROCHLORIDE TABLETS USP 1000 | 58 | $3.6M | 2.0% |
| 2 | METFORMIN HYDROCHLORIDE TABLETS USP 1000 | 40 | $2.9M | 1.6% |
| 3 | METFORMIN HYDROCHLORIDE TABLETS USP 500M | 13 | $1.4M | 0.8% |
| 4 | METFORMIN HCL ER 500 MG 500S TABLETSNDC NO.67877-159-05 METFORMIN HYDROCHLORIDE EXTENDED RELEASED TABLETS USP 500 | 12 | $1.3M | 0.7% |
| 5 | METFORMIN HCL ER 500MG 500'S (EACH TABLET CONTAIN METFORMIN HYDROCHLORIDE EXTENDED RELEASED TABLETS USP 500MG ) | 12 | $1.2M | 0.7% |
| 6 | METFORMIN HCL ER 500MG 500'S (TABLETS) (EACH TABLET CONTAIN METFORMIN HYDROCHLORIDE EXTENDED RELEASED TABLETS USP 500MG) | 14 | $1.2M | 0.6% |
| 7 | METFORMIN HCL ER 500 MG 500S (TABLETS)NDC NO.67877-159-05 (METFORMIN HYDROCHLORIDE EXTENDED RELEASED TABLETS USP 500MG | 16 | $1.2M | 0.6% |
| 8 | Metformin HCl BB 500mg T 500s MetforminHydrochloride Tablets USP 500 MG | 9 | $1.1M | 0.6% |
| 9 | METFORMIN HCL ER 500 MG 500 S TABLETS NDC NO 67877 159 05 Each Tablet Contain Metformin Hydrochloride Exte | 12 | $1.1M | 0.6% |
| 10 | METFORMIN HCL ER 500 MG 500'S (TABLETS) NDC NO.67877-159-05 (Each Tablet Contain Metformin Hydrochloride Exte | 10 | $972.5K | 0.5% |
Showing top 10 of 2,121 Metformin formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 76%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD ICD handles the highest volume with 1145 shipments. Transit time averages 18 days by sea.
Market Dynamics
India's metformin exports to United States are driven primarily by a handful of large-scale manufacturers. GRANULES INDIA LIMITED with 2,114 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 38 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — GRANULES INDIA LIMITED, INVENTIA HEALTHCARE LIMITED, ZYDUS LIFESCIENCES LIMITED — together account for 81% of total trade value on this route. The average shipment value of $46.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as metformin hydrochloride tablets usp 1000 and metformin hydrochloride tablets usp 500m, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, GRANULES PHARMACEUTICALS INC is the largest importer with 625 shipments worth $36.6M USD — representing 20% of all metformin imports from India on this route. A total of 97 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $180.6M
- Avg. Shipment
- $46.4K
- Suppliers
- 38
- Buyers
- 97
- Transit (Sea)
- ~18 days
- Annual Growth
- +12.0%
Reverse Direction
United States → India — Metformin (Import)Other Metformin Routes
Unlock the Full India to United States Metformin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 3,889 shipments on this route.
Frequently Asked Questions — India to United States Metformin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Metformin to United States?
The leading Indian exporters of Metformin to United States are GRANULES INDIA LIMITED, INVENTIA HEALTHCARE LIMITED, ZYDUS LIFESCIENCES LIMITED. GRANULES INDIA LIMITED holds the largest market share at approximately 60% of total trade value on this route.
Q What is the total value of Metformin exports from India to United States?
India exports Metformin to United States worth approximately $180.6M USD across 3,889 recorded shipments. The average value per shipment is $46.4K USD.
Q Which ports does India use to ship Metformin to United States?
The most active port of origin is HYDERABAD ICD with 1145 shipments. Indian exporters primarily use sea freight for this route, with 76% of shipments going by sea and 23% by air.
Q How long does shipping take from India to United States for Metformin?
The average transit time for Metformin shipments from India to United States is approximately 18 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United States Metformin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 12.0% with demand growth tracking at 10.7%. The route is ranked #6 among India's top Metformin export destinations globally.
Q How many suppliers are active on the India to United States Metformin route?
There are currently 38 active Indian suppliers exporting Metformin to United States. The market is moderately concentrated with GRANULES INDIA LIMITED accounting for 60% of total shipment value.
Q Who are the main importers of Metformin from India in United States?
The leading importers of Indian Metformin in United States include GRANULES PHARMACEUTICALS INC, GRANULES PHARMACEUTICALS, INC, ASCEND LABORATORIES LLC, GRANULES PHARMACEUTICALS, INC., EVERSANA LIFE SCIENCE SERVICES. GRANULES PHARMACEUTICALS INC is the largest buyer with 625 shipments worth $36.6M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Metformin.
- 2.Supplier/Buyer Matching: 38 Indian exporters and 97 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 3,889 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,889 Verified Shipments
38 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists